Global Flow Cytometry Market, by Technology (Cell based and Bead based), by Product Type (Analyzer, Sorter, and Reagent & Consumables), by Application (Research, Clinical, and Industrial), by End User (Hospital, Clinical Testing Laboratories, and Research Laboratories), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 3,886.1 million in 2018 and is expected to exhibit a CAGR of 10.2% over the forecast period (2019-2027), as highlighted in a new report published by Coherent Market Insights.

Flow cytometry is a procedure based on laser technology, which is employed in cell counting, cell sorting, protein engineering, and biomarker detection. Flow cytometer are used in cytology, hematology, immunology, and microbiology, among other research fields. Moreover, advancements in the technology of flow cytometry such as usage of more robust photodetectors and new laser emitters, use of LED lamps as emitter, and changes in analytical capacity in flow cytometry are expected to drive growth of the flow cytometry market. This technique allows researchers to get highly specific information about individual cells. The increasing application of flow cytometry in diagnostic tests such as CD4 test for HIV are expected to drive growth of the market.

The increasing novel application of flow cytometer in cytogenomics, proteomics, and marine cell biology are expected to drive the flow cytometry market growth over the forecast period. Whereas, increasing demand for flow cytometry in hospitals and diagnostic centers for effective diagnosis as well as monitoring of diseases are expected to fuel growth of the market. However, limited availability of technical expertise for handling and managing the testing services for the viral vector and plasmid DNA are expected to hamper growth of the flow cytometry market.

Key players in the market are focused on launching and approval of new products, which in turn, is expected to boost the market growth over the forecast period. For instance, in August 2017, Beckman Coulter, Inc. (U.S.), received the U.S. FDA approval for its clinical flow cytometry product, the Navios EX flow cytometer, to be used in the clinical laboratory in the US.  The Navios EX delivers accurate, high complexity immunophenotyping using Tetra reagents. The compact, 10-color Navios EX incorporates the advanced optics and laser technology of the company’s award-winning CytoFLEX research flow cytometer. From this product apporval Beckman Coulter, Inc. enhanced their product portfolio in flow cytometry.

Browse 23 Market Data Tables and 26 Figures spread through 145 Pages and in-depth TOC on “Flow Cytometry Market” - Global forecast to 2027, by Technology (Cell-based and Bead-based), by Product Type (Analyzer, Sorter, and Reagent & Consumables), by Application (Research, Clinical, and Industrial), by End User (Hospital, Clinical Testing Laboratories, and Research laboratories), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in the Flow Cytometry Market, click the link below:

https://www.coherentmarketinsights.com/market-insight/flow-cytometry-market-1152

Asia Pacific is expected to offer lucrative market opportunity in the flow cytometry market over the forecast period, owing to rising incidence of HIV and cancer cases in the region. For instance, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS), in 2016, around 4.9 million HIV infected people aged 15 years and above were living in the Asia Pacific, which in turn is expected to propel the market growth in Asia Pacific over the forecast period.

Key Takeaways of the Flow Cytometry Market:

  • The global flow cytometry market is expected to exhibit a CAGR of 10.2% over the forecast period, owing to increasing product launches that are expected to boost growth of the flow cytometry market over the forecast period. For instance, in November 2016, Sysmex Partec GmbH launched the RF-500 flow cytometer for the research and industrial domains.
  • Among technology, cell-based segment held a dominant position in the flow cytometry market in 2018, owing to better results in with less time, which is leading to product development and launches. For instance, in February 2014, Bio-Rad Laboratories, Inc., announced the launch of its ReadiLink antibody labeling kits, one of the market’s simplest antibody conjugation solution for labeling microscale amounts (50-100 µg) of antibody. These kits are ideal for researchers interested in labelling their own antibodies for flow cytometry and cell sorting applications.
  • .Companies operating in the global flow cytometry market include Becton Dickinson and Company, General Electric Company, Luminex Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec GmbH, Merck & Co Inc., Sysmex Corporation, Agilent Technologies, Inc., and Danaher Corporation
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner